The seminar showcased the wide range of CNS expertise and its collaborative relationships with industry.
This work contains contributions by CNS’s Miles Pomper, Allison Berke, Ferenc Dalnoki-Veress, and George M. Moore.
Staffers learn how easy it might be to genetically engineer a pathogen and how synthetic biology can speed up the manufacturing of medicinal compounds.
Proper federal oversight could make invisible labs more visible and prevent unsafe labs from working with dangerous pathogens.
CNS Founding Director William Potter expressed great enthusiasm about the appointment, which he characterized as “adding significantly to the scientific expertise of CNS related to both bioengineering and cybersecurity.”
Eighteen senior and mid-level government employees from Malaysia and the Philippines traveled to CNS for a two-week in-person workshop.
